NHC (National Healthcare Corp.)
Insider Trading Activity
Every open-market purchase and sale reported by NHC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-14 | BRIAN F KIDD | SVP, CFO | Sell | — | — |
| 2026-09-14 | Josh A McCreary | Senior VP & General Counsel | Sell | — | — |
| 2026-09-02 | BEN ANDERSON FLATT SR | Senior VP & CIO | Sell | — | — |
| 2026-08-28 | David R. Gifford | Director | Sell | — | — |
| 2026-08-21 | David R. Gifford | Director | MIXED | — | — |
| 2026-08-20 | Stephen Fowler Flatt | CEO | Sell | — | — |
| 2026-08-17 | David R. Gifford | Director | M | — | — |
| 2026-06-23 | EMIL E HASSAN | Director | Sell | — | — |
| 2026-06-18 | EMIL E HASSAN | Director | Sell | — | — |
| 2026-06-18 | BRIAN F KIDD | SVP, CFO | G | — | — |
| 2026-06-10 | ROBERT G ADAMS | Director | MIXED | — | — |
| 2026-06-02 | Lisa Piercey | Director | Buy | — | — |
| 2026-05-27 | BEN ANDERSON FLATT SR | Senior VP & CIO | MIXED | — | — |
| 2026-05-22 | RICHARD F LAROCHE JR | Director | Sell | — | — |
| 2026-05-22 | Stephen Fowler Flatt | CEO | G | — | — |
| 2026-05-20 | Timothy J. Shelly | Sr.VP Operations | Sell | — | — |
| 2026-05-18 | BRIAN F KIDD | SVP, CFO | MIXED | — | — |
| 2026-05-18 | Stephen Fowler Flatt | CEO | MIXED | — | — |
| 2026-05-08 | William A. Adams | Director | A | — | — |
| 2026-05-08 | Sandra Y. Trail | Director | M | — | — |
| 2026-05-07 | William A. Adams | Director | A | — | — |
| 2026-05-07 | David R. Gifford | Director | A | — | — |
| 2026-05-07 | Lisa Piercey | Director | A | — | — |
| 2026-05-07 | RICHARD F LAROCHE JR | Director | A | — | — |
| 2026-05-07 | JAMES PAUL ABERNATHY | Director | A | — | — |
| 2026-05-07 | Sandra Y. Trail | Director | A | — | — |
| 2026-05-07 | EMIL E HASSAN | Director | A | — | — |
| 2026-05-07 | ROBERT G ADAMS | Director | A | — | — |
| 2026-05-06 | RICHARD F LAROCHE JR | Director | M | — | — |
| 2026-05-01 | EMIL E HASSAN | Director | M | — | — |
| 2026-04-24 | Vicki L Dodson | Sr.VP Patient Srvcs | MIXED | — | — |
| 2026-04-14 | BEN ANDERSON FLATT SR | Senior VP & CIO | F | — | — |
| 2026-04-13 | BEN ANDERSON FLATT SR | Senior VP & CIO | MIXED | — | — |
| 2026-03-18 | Vicki L Dodson | Sr.VP Patient Srvcs | MIXED | — | — |
| 2026-03-16 | Stephen Fowler Flatt | CEO | M | — | — |
| 2026-03-16 | BRIAN F KIDD | SVP, CFO | M | — | — |
| 2026-03-10 | JAMES PAUL ABERNATHY | Director | M | — | — |
| 2026-03-06 | Vicki L Dodson | Sr.VP Patient Srvcs | MIXED | — | — |
| 2026-03-06 | Timothy J. Shelly | Sr.VP Operations | MIXED | — | — |
| 2026-03-06 | BEN ANDERSON FLATT SR | Senior VP & CIO | MIXED | — | — |
| 2026-03-06 | BRIAN F KIDD | SVP, CFO | MIXED | — | — |
| 2026-03-06 | Josh A McCreary | Senior VP & General Counsel | MIXED | — | — |
| 2026-03-03 | Stephen Fowler Flatt | CEO | A | — | — |
| 2026-03-03 | Josh A McCreary | Senior VP & General Counsel | A | — | — |
| 2026-03-03 | BEN ANDERSON FLATT SR | Senior VP & CIO | A | — | — |
| 2026-03-03 | Vicki L Dodson | Sr.VP Patient Srvcs | A | — | — |
| 2026-03-03 | Timothy J. Shelly | Sr.VP Operations | A | — | — |
| 2026-03-03 | BRIAN F KIDD | SVP, CFO | A | — | — |
| 2026-03-03 | Stephen Fowler Flatt | CEO | MIXED | — | — |
| 2026-02-25 | Stephen Fowler Flatt | CEO | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 1,030,887 | — |
| — | Director | 430,341 | — |
| — | Sr. Vice President, Controller | 428,059 | — |
| — | SVP-Anc.Svcs & Corp. Relations | 360,114 | — |
| — | Director | 304,979 | — |
| — | Sr. Vice President & Treasurer | 257,123 | — |
| — | Director | 235,760 | — |
| — | Director | 166,850 | — |
| — | President & COO | 158,460 | — |
| — | Director | 156,500 | — |
| — | Sr. VP - Patient Services | 113,784 | — |
| — | Director | 65,595 | — |
| — | CEO | 65,487 | — |
| — | Sr. Vice President, Homecare | 49,288 | — |
| — | Director | 43,302 | — |
| — | Senior VP & General Counsel | 24,453 | — |
| — | SVP, CFO | 23,183 | — |
| — | Senior VP & CIO | 18,636 | — |
| — | Sr.VP Patient Srvcs | 18,412 | — |
| — | Sr. Vice President, Corp. Aff. | 17,500 | — |
| — | Director | 10,640 | — |
| — | Senior VP & General Counsel | 9,979 | — |
| — | SVP, Anc Srvcs & Srvc Strategy | 9,346 | — |
| — | SVP & Treasurer | 8,017 | — |
| — | Sr.VP Operations | 1,294 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NHC quote page; the site-wide leaderboard is on the insider transactions hub.